2020-2025 Global Biopharmaceutical CMO & CRO Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
- 141791
- 15-Jun
- Pharmaceutical
- 106
- MRR
-
Report Details
A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. A contract research organization (CRO) is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. This report elaborates the market size, market characteristics, and market growth of the Biopharmaceutical CMO & CRO industry, and breaks down according to the type, application, and consumption area of Biopharmaceutical CMO & CRO. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biopharmaceutical CMO & CRO in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19. In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy. Key players in the global Biopharmaceutical CMO & CRO market covered in Chapter 13: CELONIC AG ProBioGen Boehringer Ingelheim GmbH JRS PHARMA TOYOBO CO., LTD. CMC Biologics Patheon WuXi Biologics Samsung BioLogics AbbVie, Inc. DPx Binex Co., Ltd. LONZA Rentschler Biotechnologie GmbH BIOMEVA GmbH FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Inno Biologics Sdn Bhd In Chapter 6, on the basis of types, the Biopharmaceutical CMO & CRO market from 2015 to 2025 is primarily split into: Mammalian Non-mammalian In Chapter 7, on the basis of applications, the Biopharmaceutical CMO & CRO market from 2015 to 2025 covers: Contract Manufacturing Contract Research Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5: United States Europe China Japan India Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12: North America (Covered in Chapter 8) United States Canada Mexico Europe (Covered in Chapter 9) Germany UK France Italy Spain Others Asia-Pacific (Covered in Chapter 10) China Japan India South Korea Southeast Asia Others Middle East and Africa (Covered in Chapter 11) Saudi Arabia UAE South Africa Others South America (Covered in Chapter 12) Brazil Others Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025
-
Table Of Content
Table of Content 1 Biopharmaceutical CMO & CRO Market - Research Scope 1.1 Study Goals 1.2 Market Definition and Scope 1.3 Key Market Segments 1.4 Study and Forecasting Years 2 Biopharmaceutical CMO & CRO Market - Research Methodology 2.1 Methodology 2.2 Research Data Source 2.2.1 Secondary Data 2.2.2 Primary Data 2.2.3 Market Size Estimation 2.2.4 Legal Disclaimer 3 Biopharmace
-
Inquiry Before Buying
-
Request Sample